|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 31/519 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| C07D 487/04 | (2006.01) |
| (11) | Patento numeris | 1296984 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 01938263.9 |
| Europos patento paraiškos padavimo data | 2001-06-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2003-04-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2005-05-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2001/006747 |
| Data | 2001-06-13 |
| (87) | Numeris | WO 2001/098302 |
| Data | 2001-12-27 |
| (30) | Numeris | Data | Šalis |
| 00202181 | 2000-06-22 | EP |
| (72) |
VENET, Marc, Gaston Janssen-Cilag S.A., FR
ANGIBAUD, Patrick, René Janssen-Cilag S.A., FR
END, David, William Janssen Pharmaceutica Inc., US
|
| (73) |
JANSSEN PHARMACEUTICA N.V.,
Patent Department Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | PHARMACEUTICAL COMPOSITION COMPRISING A FARNESYL TRANSFERASE INHIBITING 1,2-ANNELATED QUINOLINE ENANTIOMER |
| PHARMACEUTICAL COMPOSITION COMPRISING A FARNESYL TRANSFERASE INHIBITING 1,2-ANNELATED QUINOLINE ENANTIOMER |